Artificial intelligence (AI) has enabled scientists at the University of British Columbia to discover a high-risk endometrial cancer type and a...
Vous n'êtes pas connecté
A discovery by researchers at the University of British Columbia, Canada, promises to improve care for patients with endometrial cancer, the most common gynaecologic malignancy. Using artificial intelligence (AI) to spot patterns across thousands of cancer cell images, the researchers have pinpointed a distinct subset of endometrial cancer that puts patients at much greater risk [...]
Artificial intelligence (AI) has enabled scientists at the University of British Columbia to discover a high-risk endometrial cancer type and a...
With a new five-year, $2.78 million grant from the National Institutes of Health and National Cancer Institute, researchers at Case Western...
Researchers at the University of Michigan Rogel Cancer Center have developed a 15-gene signature that helps classify clear cell kidney cancer patients...
Researchers from the University of Helsinki and HUS investigated the effects of recurring mutations in the KLHL6 gene in diffuse large B-cell...
Researchers have identified a biomarker that can help determine which medlinkrenal cancer/medlink patients are at a higher risk of recurrence. The
A new artificial intelligence (AI) tool that can help to select the most suitable treatment for cancer patients has been developed by researchers at...
The European Medicines Agency accepts GSK's application for the expanded use of Jemperli plus chemotherapy to include all adult patients with primary...
A new study published in JAMA Network Open by an international cohort of researchers provides the latest data on the effectiveness of treating...
An analysis of data from a randomised clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib,...
Scientists behind a new type of immunotherapy are demonstrating significant effects in laboratory experiments in cell samples from patients with the...